Sign in
CompletedNo phase

Real-world Evaluation of the Effectiveness of Immunoglobulin-Histamine Complex, IHC (Histoglob) in Chronic Urticaria

Key facts

Who runs it
Bharat Serums and Vaccines Limited
Where
India40 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
660 people enrolled
Started
31 Dec 2025
Ended
3 Aug 2026
Type of study
Observational
Treatments tested
  • Antihistaminics, H2 blockers, Leukotriene antagonists, Immunoglobulin/Histamine Complex (IHC) Injection
Record updated
2 October 2026

Who can take part

Age
13 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Male or female patients aged ≥13 years
  • Able and willing to provide written informed consent (or assent where applicable)
  • Diagnosed with chronic urticaria with UAS7 prior to enrollment already on first line of treatment for Chronic Urticaria
  • Prescribed Histoglob injections for the first time at the discretion of treating physician as part of routine car

Who cannot take part

  • Known allergy or hypersensitivity to Histoglob or human immunoglobulin product
  • Patients with acute allergic attack
  • History of malignancy or any condition requiring immunosuppressive therapy other than study indication
  • Any other condition or circumstance that, in the opinion of the study physician, makes the patient unsuitable for study participation
  • Pregnant or lactating women
  • Participation in any other clinical study

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This is a prospective, multicentre, non-interventional, observational, real-world evidence (RWE) study designed to evaluate the effectiveness and safety of Immunoglobulin/Histamine Complex (IHC) in patients with Chronic Urticaria in India.

The group in the trial

  • Chronic Urticaria Group

    Patients with Chronic Urticaria on the first line of treatment like antihistaminics and not controlled requiring histaglobulin treatment

    Treatment: Antihistaminics, H2 blockers, Leukotriene antagonists, Immunoglobulin/Histamine Complex (IHC) Injection

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Real-world Evaluation of the Effectiveness of Immunoglobulin-Histamine Complex; IHC (Histoglob) in the Management of Chronic Urticaria: A Prospective, Multicenter, Observational Study.
Record updated
2 October 2026